NKX2-3's Role in Inflammatory Bowel Disease
Author Information
Author(s): Yu Wei, Hegarty John P., Berg Arthur, Chen Xi, West Gail, Kelly Ashley A., Wang Yunhua, Poritz Lisa S., Koltun Walter A., Lin Zhenwu
Primary Institution: Pennsylvania State University
Hypothesis
NKX2-3 regulates genes involved in inflammatory bowel disease (IBD) pathogenesis in human intestinal microvascular endothelial cells.
Conclusion
NKX2-3 may play an important role in IBD pathogenesis by regulating endothelin-1 and VEGF signaling in human intestinal microvascular endothelial cells.
Supporting Evidence
- NKX2-3 expression was suppressed by shRNA in two HIMEC lines.
- 1746 genes were affected by NKX2-3 knockdown in HIMEC 21B cells.
- Expression levels of NKX2-3, VEGFA, PI3K, AKT, and eNOS are increased in intestinal tissues from IBD patients.
- Correlation analysis showed a positive correlation between NKX2-3 and VEGFA expression.
- NKX2-3 knockdown activated MAPK through the EDN1 pathway.
Takeaway
NKX2-3 is a gene that helps control other genes involved in inflammation, and it might be important for understanding diseases like Crohn's and colitis.
Methodology
The study used shRNA to suppress NKX2-3 expression in two human intestinal microvascular endothelial cell lines and analyzed gene expression using cDNA microarray.
Participant Demographics
{"Crohn's_disease":{"n":31,"sex":"14 males, 17 females","average_age":39.9},"Ulcerative_colitis":{"n":32,"sex":"16 males, 16 females","average_age":48.4}}
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website